As effort gets harder, your body leans more on glucose because it needs energy faster
In the Noom program, a doctor always determines whether medication is appropriate and which medication to prescribe to each patient, whether brand name, generic, or personalized via a 503a pharmacy
[5] When Rybelsus is used with insulin or sulfonylureas, there is an increased risk of hypoglycaemia, and dose reductions of these medications may be needed
For that reason, I do think its probably going to be scalable to hundreds of thousands if not millions of people eventually. Further reading: Evolv launches peptide that engages GLP-1 receptors as new biomimetics category emerges Where Siddhi Capital is placing its bets: GLP-1 is our AI
C., Lu L., Cao Y., Sun R
So the CMS plan was to stand up the Bridge program and quickly transition to the BALANCE program (also a CMMI model)